Adrenal insufficiency attributable to adrenal hemorrhage: long-term follow-up with reference to glucocorticoid and

Maryam Jahangir-Hekmat1, Harris C Taylor, Howard Levin

  • 1Division of Endocrinology, Fairview Hospital System and Cleveland Clinic Health System, Cleveland Clinic, Cleveland, Ohio, USA.

Insights

Long-term follow-up reveals patients with acute adrenal hemorrhage-induced adrenal insufficiency do not require prolonged mineralocorticoid replacement. Some patients show improved cortisol function, with one recovering normal adrenal function.

Area of Science:

  • Endocrinology
  • Adrenal Gland Physiology
  • Internal Medicine

Background:

  • Acute adrenal hemorrhage can lead to adrenal insufficiency.
  • Long-term outcomes for patients with this condition are not well-documented.

Observation:

  • This study followed four patients with acute bilateral adrenal hemorrhage for 6.5 to 19 years.
  • Assessed requirements for glucocorticoid and mineralocorticoid replacement.
  • Evaluated adrenal function through clinical assessment and laboratory tests.

Findings:

  • No long-term mineralocorticoid replacement was needed in any patient.
  • Three of four patients showed improved cortisol levels, with one achieving normal function without replacement.
  • Histological examination revealed regeneration and myelolipoma in one patient.
  • Adrenal glands were atrophic in three patients on computed tomography.

Implications:

  • Patients with adrenal insufficiency due to adrenal hemorrhage may not require lifelong mineralocorticoid therapy.
  • Endogenous glucocorticoid function can recover in some individuals.
  • These findings challenge previous assumptions about the permanence of adrenal insufficiency after hemorrhage.
Abstract

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...